Literature DB >> 784932

Persistent pulmonary hypertension of the newborn infant.

D L Levin, M A Heymann, J A Kitterman, G A Gregory, R H Phibbs, A M Rudolph.   

Abstract

Persistent pulmonary hypertension of the newborn infant can be difficult to distinguish from other cardiopulmonary causes of cyanosis during the newborn period. Infants with PPHN have cyanosis, tachypnea, acidemia, normal pulmonary parenchymal markings on the chest radiography, and anatomically normal hearts. We have identified and treated 11 infants and have noted several signs and symptoms not previously emphasized. These are cineangiocardiographic evidence of atrioventricular valve insufficiency in association with systolic murmurs and slow ventricular emptying, apnea, hypocalcemia, only a small rise in abdominal aortic blood oxygen tension during breathing of 100% oxygen, and no response to continuous positive airway pressure. Right-to-left shunting through the patent ductus arteriosus was documented in nine infants: in all six of those in whom simultaneous temporal and abdominal aortic blood oxygen tension measurements were made; in three by means of cardiac catheterization. Ten infants survived after variable courses and treatments which makes it difficult to ascribe improvement to any one therapy. The distinct increase in blood oxygen tension with tolazoline HCl and curare in some instances is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 784932     DOI: 10.1016/s0022-3476(76)80405-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  32 in total

1.  Non-invasive assessment of pulmonary arterial pressure in healthy neonates.

Authors:  J R Skinner; R J Boys; S Hunter; E N Hey
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

2.  Persistent fetal circulation: an evolving clinical and radiographic concept of pulmonary hypertension of the newborn.

Authors:  D F Merten; B W Goetzman; R P Wennberg
Journal:  Pediatr Radiol       Date:  1977-09-01

3.  A new side effect of inhaled nitric oxide in neonates and infants with pulmonary hypertension: functional impairment of the neutrophil respiratory burst.

Authors:  P Gessler; T Nebe; A Birle; W Mueller; W Kachel
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

Review 4.  How valid are animal models to evaluate treatments for pulmonary hypertension?

Authors:  Maria E Campian; Maxim Hardziyenka; Martin C Michel; Hanno L Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09       Impact factor: 3.000

Review 5.  The Robyn Barst Memorial Lecture: Differences between the fetal, newborn, and adult pulmonary circulations: relevance for age-specific therapies (2013 Grover Conference series).

Authors:  Steven H Abman; Christopher Baker; Jason Gien; Peter Mourani; Csaba Galambos
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

6.  Congenital diaphragmatic hernia. New concept in management.

Authors:  S J Shochat; R L Naeye; W D Ford; V Whitman; M J Maisels
Journal:  Ann Surg       Date:  1979-09       Impact factor: 12.969

7.  Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signaling.

Authors:  Jason Gien; Gregory J Seedorf; Vivek Balasubramaniam; Neil Markham; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2007-09-06       Impact factor: 21.405

8.  Usefulness of continuous positive airway pressure in differential diagnosis of cardiac from pulmonary cyanosis in newborn infants.

Authors:  P S Rao; B L Marino; A F Robertson
Journal:  Arch Dis Child       Date:  1978-06       Impact factor: 3.791

9.  Fasudil inhibits the myogenic response in the fetal pulmonary circulation.

Authors:  Pierre Tourneux; Marc Chester; Theresa Grover; Steven H Abman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-01       Impact factor: 4.733

10.  Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs.

Authors:  S H Abman; P F Shanley; F J Accurso
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.